Grenada vs Jordan: Lung cancer death rate in men vs. women
Grenada
16.43 deaths per 100,000 people
in 2023
Jordan
15.08 deaths per 100,000 people
in 2018
Grenada rank
68th
Jordan rank
70th
Lung cancer death rate in men vs. women over time
- Grenada
- Jordan
How they compare
Grenada currently reports 16.43 deaths per 100,000 people against 15.08 deaths per 100,000 people in Jordan, a difference of 1.35 deaths per 100,000 people.
That makes Grenada's figure about 1.1 times Jordan's.
The two have swapped places 2 times across 9 shared years of data; in 2008 it was Jordan ahead.
Grenada ranks 68th and Jordan ranks 70th of 111 countries.
Jordan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Grenada | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.43 deaths per 100,000 people | 18.32 deaths per 100,000 people | 4.89 deaths per 100,000 people | Jordan |
| 2010s | 13.54 deaths per 100,000 people | 16.96 deaths per 100,000 people | 3.42 deaths per 100,000 people | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher lung cancer death rate in men vs. women, Grenada or Jordan?
- Grenada, at 16.43 deaths per 100,000 people against 15.08 deaths per 100,000 people in Jordan as of 2023.
- What is the difference in lung cancer death rate in men vs. women between Grenada and Jordan?
- 1.35 deaths per 100,000 people, with Grenada ahead.
- How many years of comparable data are there for Grenada and Jordan?
- 9 years are reported by both, from 2008 to 2018.
- How do Grenada and Jordan rank globally for lung cancer death rate in men vs. women?
- Grenada ranks 68th and Jordan ranks 70th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) β with minor processing by Our World in Data, published as Lung cancer death rate in men vs. women. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from trachea, bronchus, lung cancers in males in those aged all ages per 100,000 people.